Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Atossa Therapeutics, Inc. ATOS

Set alert

Price alert · ATOS

All alert types
2.30 USD +0.13 +5.99%

At close

2.18 -0.12 -5.22%

Pre-market · Nov 3, 8:34 AM ET

Bid
2.24 × 2
Ask
2.30 × 3
2.21 Day range 2.40
1.70 52-week range 14.85
YTD
-74.01%
1 year
-82.77%
Open
2.21
Prev close
2.17
Mkt cap
22.95M
Vol
66.00K
Avg vol
71.46K
EPS
-4.45
P/E
0.00
Div yield
0.00%
More statistics
Low
2.21
High
2.40
Forward P/E
-3.81
Beta
1.23
Short ratio
14.73
Inst. own
28.16%
Dividend
0.00
Ex-div date
50-d avg
1.31
200-d avg
1.39
1y target
6.00

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Apr 1, 2024Earnings: -0.06; estimate -0.05; surprise -20%
  • Nov 5, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Feb 2, 2026Split: 1 for 15
Signals (34)
NameDateAgo
MACD: Sell SignalJan 1, 202610 months ago
SMA: BearishNov 1, 20251 year ago
SMA: BullishSep 1, 20251 year ago
MACD: Buy SignalSep 1, 20251 year ago
MACD: Sell SignalAug 1, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
MACD: Sell SignalMar 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BearishNov 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
SMA: BullishFeb 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishAug 1, 20233 years ago
SMA: BullishMay 1, 20233 years ago
SMA: BearishNov 1, 20215 years ago
SMA: BearishOct 1, 20215 years ago
SMA: BullishApr 1, 20215 years ago
SMA: BearishMar 1, 20215 years ago
SMA: BullishFeb 1, 20215 years ago

Newest 20 of 34.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 6.00 +160.9% upside
Target (low)
4.00
Target (mean)
6.00
Target (high)
7.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ATOS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.06-0.07 – -0.05-0.060.0%00.0%4
Next quarter-0.06-0.06 – -0.06-0.05-20.0%00.0%1
Current year-0.2125-0.22 – -0.20-0.24+11.5%00.0%4
Next year-0.25-0.29 – -0.20-0.2125-17.6%00.0%4

Upgrades and downgrades

The latest rating changes

ATOS analyst upgrades and downgrades
DateFirmActionFromTo
Dec 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 9, 2024Ascendiant CapitalMaintainedBuyBuy
Nov 13, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 5, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 11, 2024Ascendiant CapitalMaintainedBuyBuy
Aug 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 28, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 20, 2024Cantor FitzgeraldReiterated—Overweight
Jun 6, 2024Ascendiant CapitalMaintainedBuyBuy
May 14, 2024Cantor FitzgeraldReiterated—Overweight
May 13, 2024HC Wainwright & Co.MaintainedBuyBuy
Apr 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 2, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 12, 2024HC Wainwright & Co.Initiated—Buy
Sep 8, 2023Cantor FitzgeraldInitiated—Overweight
Sep 17, 2020Ascendiant CapitalInitiated—Buy
Dec 18, 2019Maxim GroupUpgradeHoldBuy
Jan 26, 2018Maxim GroupInitiated—Buy
Oct 7, 2013Sidoti & Co.DowngradeBuyNeutral
Apr 15, 2013Sidoti & Co.Initiated—Buy
Mar 20, 2013Dawson JamesDowngradeMarket OutperformBuy